1. Treatment and outcome of pediatric intracranial ependymoma after first relapse

   • Zhi-ming Liu
   • Zhe Han
   • Yong-ji Tian

   Clinical Study 28 February 2022 Pages: 385 - 396

   

2. Multisession radiosurgery for grade 2 (WHO), high risk meningiomas. A phase II clinical trial

   • Marcello Marchetti
   • Valentina Pinzi
   • Laura Fariselli

   Clinical Study 04 April 2022 Pages: 397 - 403

   

3. Contrast enhancing pattern on pre-treatment MRI predicts response to anti-angiogenic treatment in recurrent glioblastoma: comparison of bevacizumab and temozolomide treatment

   • Hye Hyeon Moon
   • Ji Eun Park
   • Ho Sung Kim

   Clinical Study 11 March 2022 Pages: 405 - 415

   

4. A volume matched comparison of survival after radiosurgery in non-small cell lung cancer patients with one versus more than twenty brain metastases

   • Zhishuo Wei
   • Ajay Niranjan
   • L. Dade Lunsford

   Clinical Study 22 March 2022 Pages: 417 - 423

   

5. Disease Control after Radiotherapy for Adult Craniopharyngioma: Clinical Outcomes from a Large Single-Institution Series

   • Michael S. Rutenberg
   • Adam L. Holtzman
   • Robert J. Amdur

   Clinical Study 12 March 2022 Pages: 425 - 433

   

6. Transcranial magnetic stimulation for post-operative neurorehabilitation in neuro-oncology: a review of the literature and future directions

   • Evan H. Einstein
   • Nicholas B. Dadario
   • Randy S. D’Amico

   Topic Review 25 March 2022 Pages: 435 - 443

   

7. Correction to: Transcranial magnetic stimulation for post-operative neurorehabilitation in neuro-oncology: a review of the literature and future directions

   • Evan H. Einstein
   • Nicholas B. Dadario
   • Randy S. D’Amico

   Correction 19 April 2022 Pages: 445 - 445

8. Managing cancer and living meaningfully (CALM) in adults with malignant glioma: a proof-of-concept phase IIa trial

   • Ashlee R. Loughan
   • Kelcie D. Willis
   • Leroy Thacker

   Clinical Study 18 April 2022 Pages: 447 - 456

   

9. Quantifying intraventricular drug delivery utilizing programmable ventriculoperitoneal shunts as the intraventricular access device

   • Sheila S. McThenia
   • Neeta Pandit-Taskar
   • Kim Kramer

   Clinical Study 11 April 2022 Pages: 457 - 463

   

10. The posterior fossa syndrome questionnaire: using science to inform practice

    • Molly E. Wickenhauser
    • Raja B. Khan
    • Heather M. Conklin

    Clinical Study 05 April 2022 Pages: 465 - 473

    

11. Supportive care of patients diagnosed with high grade glioma and their carers in Australia

    • Georgia K. B. Halkett
    • Melissa N. Berg
    • Anna K. Nowak

    Clinical Study Open access 09 April 2022 Pages: 475 - 485

    

12. The burden of a brain tumor: guiding patient centric care in neuro-oncology

    • Ashlee R. Loughan
    • Morgan Reid
    • Karen Lo

    Research 08 April 2022 Pages: 487 - 498

    

13. DICER1 mutations in primary central nervous system tumors: new insights into histologies, mutations, and prognosis

    • Kevin X. Liu
    • Helen H. Shang
    • Daphne A. Haas-Kogan

    Research 06 April 2022 Pages: 499 - 510

    

14. Gyriform infiltration as imaging biomarker for molecular glioblastomas

    • Emmanuel Mesny
    • Marc Barritault
    • François Ducray

    Clinical Study 01 April 2022 Pages: 511 - 521

    

15. Diaph3 underlines tumor cell heterogeneity in glioblastoma with implications for treatment modalities resistance

    • George S. Stoyanov
    • Emran Lyutfi
    • Peter Ghenev

    Research 05 April 2022 Pages: 523 - 531

    

16. Immune-related aseptic meningitis and strategies to manage immune checkpoint inhibitor therapy: a systematic review

    • Simon Nannini
    • Larysa Koshenkova
    • Roland Schott

    Topic Review Open access 13 April 2022 Pages: 533 - 550

    

17. Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study

    • F. Mo
    • S. Meletti
    • R. Rudà

    Clinical Study 09 April 2022 Pages: 551 - 559

18. MGMT gene promoter methylation by pyrosequencing method correlates volumetric response and neurological status in IDH wild-type glioblastomas

    • Tomohiro Hosoya
    • Masamichi Takahashi
    • Yoshitaka Narita

    Clinical Study Open access 10 April 2022 Pages: 561 - 571

    

19. Comment on "The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study"

    • George S. Stoyanov

    Correspondence 05 April 2022 Pages: 573 - 574

20. NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates NOTCH1-WNT5A signaling with stem cell maintenance and angiogenesis

    • Divya Kumari Singh
    • Pavan Kumar Mysuru Shivalingappa
    • Sharmila A. Bapat

    Research 17 April 2022 Pages: 575 - 591

    

21. Retraction Note to: LncRNA RP11-84E24.3 drives tumorigenesis and epithelial-to-mesenchymal transition of glioma cells by promoting TFAP2C-mediated activation of SNAI1

    • Lisha Chang
    • Jingyue Wang
    • Jiang Zhang

    Retraction Note 28 April 2022 Pages: 593 - 593